Petmed Express Stock Forecast, Price & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PETS stock has increased by 18.0% and is now trading at $30.62.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) announced its quarterly earnings results on Monday, July, 20th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.40 by $0.01. The firm earned $96.20 million during the quarter, compared to analysts' expectations of $90.96 million. Petmed Express had a net margin of 9.41% and a return on equity of 21.91%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.26 EPS.
View Petmed Express' earnings history.

Petmed Express announced a quarterly dividend on Monday, July 20th. Investors of record on Friday, July 31st will be given a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 3.66%. The ex-dividend date is Thursday, July 30th.
View Petmed Express' dividend history.

2 equities research analysts have issued twelve-month price targets for Petmed Express' stock. Their forecasts range from $20.00 to $41.00. On average, they anticipate Petmed Express' stock price to reach $30.50 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.
View analysts' price targets for Petmed Express.

Petmed Express saw a drop in short interest in August. As of August 14th, there was short interest totaling 5,990,000 shares, a drop of 12.8% from the July 30th total of 6,870,000 shares. Based on an average trading volume of 784,800 shares, the days-to-cover ratio is presently 7.6 days. Approximately 30.8% of the shares of the company are short sold.
View Petmed Express' Short Interest.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Overstock.com (OSTK), Tripadvisor (TRIP), 1-800-Flowers.Com (FLWS), Groupon (GRPN) and CarParts.com (PRTS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Alibaba Group (BABA), Cisco Systems (CSCO), Gilead Sciences (GILD), Verizon Communications (VZ), Advanced Micro Devices (AMD), Micron Technology (MU) and Netflix (NFLX).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.12%), Prudential Financial Inc. (2.10%), Man Group plc (2.02%), Bank of New York Mellon Corp (1.82%), Charles Schwab Investment Management Inc. (1.73%) and Robeco Institutional Asset Management B.V. (1.74%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni and Menderes Akdag.
View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Balyasny Asset Management LLC, Advisor Group Holdings Inc., Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express.

PETS stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Charles Schwab Investment Management Inc., Raymond James Financial Services Advisors Inc., Jefferies Group LLC, and AJO LP.
View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $30.62.

Petmed Express has a market capitalization of $620.73 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.